Literature DB >> 21703809

[Pneumonia associated with health care versus community acquired pneumonia: different entities, distinct approaches].

C Guimarães1, C Lares Santos, F Costa, F Barata.   

Abstract

Healthcare-associated pneumonia (HCAP) is now identified as a unique entity that differs from community-acquired pneumonia (CAP), and in many ways is similar to nosocomial pneumonia (NP). Patients with the diagnosis of CAP and HCAP admitted to our Pneumology Unit during one year were retrospectively analysed. The objective was to compare the characteristics and the approach of these two entities. 197 patients were included, 144 with CAP and 53 with HCAP. Sex, age, comorbilities, Pneumonia Severity Index (PSI) score, radiological involvement, bacteriology, treatment and outcomes were analysed in the 2 groups. Compared to CAP, HCAP was associated with more severe disease, a higher mortality rate and greater length of hospitalization. HCAP differed from CAP mainly in bacteriology and outcomes.
Copyright © 2010 Sociedade Portuguesa de Pneumologia. Published by Elsevier España. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21703809     DOI: 10.1016/j.rppneu.2011.01.001

Source DB:  PubMed          Journal:  Rev Port Pneumol        ISSN: 0873-2159


  3 in total

1.  Epidemiological Characterization and the Impact of Healthcare-Associated Pneumonia in Patients Admitted in a Northern Portuguese Hospital.

Authors:  Lucía Méndez; Pedro Castro; Jorge Ferreira; Cátia Caneiras
Journal:  J Clin Med       Date:  2021-11-28       Impact factor: 4.241

2.  Antibiotic Resistance Patterns of Enterobacteriaceae Isolated from Patients with Healthcare-Associated Infections.

Authors:  Young Kyun Choi; Eun Ju Byeon; Jin Ju Park; Jacob Lee; Yu Bin Seo
Journal:  Infect Chemother       Date:  2021-06

Review 3.  Classification of healthcare-associated infection: a systematic review 10 years after the first proposal.

Authors:  Teresa Cardoso; Mónica Almeida; N Deborah Friedman; Irene Aragão; Altamiro Costa-Pereira; António E Sarmento; Luís Azevedo
Journal:  BMC Med       Date:  2014-03-06       Impact factor: 8.775

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.